Predictors of response to bDMARDs and tsDMARDs in psoriatic arthritis: a pilot study on the role of musculoskeletal ultrasound

Predictors of response to bDMARDs and tsDMARDs in psoriatic arthritis: a pilot study on the role of musculoskeletal ultrasound

ObjectivesThis pilot study aimed to identify early predictors of drug retention in patients with clinically active peripheral psoriatic arthritis who initiated or switched to therapy with biologic and targeted synthetic disease-modifying antirheumatic drugs (bDMARDs and tsDMARDs).MethodsClinical and...

Full description

Saved in:

Bibliographic Details
Main Authors:	Giacomo Cozzi, Laura Scagnellato, Mariagrazia Lorenzin, Antonio Collesei, Francesca Oliviero, Amelia Damasco, Chiara Cosma, Daniela Basso, Andrea Doria, Roberta Ramonda
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-12-01
Series:	Frontiers in Medicine
Subjects:	psoriatic arthritis bDMARDs tsDMARDs ultrasound therapy response
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2024.1482894/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Difficult-to-treat psoriatic arthritis: refining the definition using a statistical model in a real-life cohort
by: Ennio Giulio Favalli, et al.
Published: (2024-12-01)

Small molecules in idiopathic inflammatory myopathies: a systematic review and a multicenter case series about Janus kinase inhibitors and apremilast
by: Chiara Rizzo, et al.
Published: (2025-01-01)

Unstable psoriasis in the setting of psoriatic arthritis: A rare presentation
by: Roma Raj, et al.
Published: (2022-01-01)

Physiopathological Aspects of Synovial Fluid and Membrane in Psoriatic Arthritis
by: Amelia Carmela Damasco, et al.
Published: (2024-11-01)

Management of tuberculosis risk, screening and preventive therapy in patients with chronic autoimmune arthritis undergoing biotechnological and targeted immunosuppressive agents
by: Andrea Picchianti-Diamanti, et al.
Published: (2025-02-01)

Real-World Persistence and Effectiveness of Upadacitinib versus Other Janus Kinase Inhibitors and Tumor Necrosis Factor Inhibitors in Australian Patients with Rheumatoid Arthritis
by: Peter Youssef, et al.
Published: (2025-01-01)

Pharmacological pain management in patients with rheumatoid arthritis: a narrative literature review
by: Natasha Cox, et al.
Published: (2025-01-01)

Improvement in rheumatoid sarcopenia with biological therapy; muscle ultrasound study
by: Zehra Özsoy, et al.
Published: (2024-11-01)

Risks of malignancies related to disease-modifying antirheumatic drugs in rheumatoid arthritis: a pharmacovigilance analysis using the FAERS database
by: Wan Xiong, et al.
Published: (2024-11-01)

Anti-Müllerian Hormone Serum Levels as Biomarker of Ovarian Reserve in Adult Women with Juvenile Idiopathic Arthritis Treated with csDMARDs and/or bDMARDs: A Pilot Study
by: Clara Di Mario, et al.
Published: (2024-10-01)

Safety and efficacy of an Anti-CD20 Monoclonal antibody (RedituxTM) In Indian patients with seropositive rheumatoid arthritis
by: Arun Hegde, et al.
Published: (2018-01-01)

How Early Should We Use b/tsDMARDs in Active PsA? - Data from a 1-year Prospective Cohort in Hong Kong
by: Wai Kit Shek, et al.
Published: (2024-01-01)

Influence of Medication on Flare Up and Infection After Elective Orthopedic Surgery in Rheumatoid Arthritis Patient – A Narrative Review
by: Yaldi Rosadi, et al.
Published: (2020-10-01)

Comparison of treatment of severe rheumatoid arthritis patients with biological agents and JAK-STAT inhibitors. An extension study
by: Małgorzata Wisłowska
Published: (2024-11-01)

Taiwan ocular inflammation society consensus recommendations for the management of juvenile idiopathic arthritis-associated uveitis
by: Wei-Dar Chen, et al.
Published: (2024-12-01)

Preferable effect of CTLA4-Ig on both bone erosion and bone microarchitecture in rheumatoid arthritis revealed by HR-pQCT
by: Naoki Iwamoto, et al.
Published: (2024-11-01)

Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis refractory to biologic therapy: 2-year clinical and radiographic results from the open-label extension of the SELECT-AXIS 2 study
by: Xenofon Baraliakos, et al.
Published: (2024-11-01)

How Are We Addressing Axial Psoriatic Arthritis in Clinical Practice?
by: Xabier Michelena, et al.
Published: (2024-10-01)

Clinical profiling of psoriatic arthritis: an observational cross-sectional study from Karnataka Psoriatic Arthritis Cohort
by: Chanakya Kodishala, et al.
Published: (2022-01-01)

Evaluation of acitretin side effects on Iraqi psoriatic patients
by: Ahmed H. Kadhim‎, et al.
Published: (2010-12-01)

Is the visceral adiposity index associated with the presence of cardiovascular risk scores and comorbidity in psoriatic disease?
by: Ahmet Omma, et al.
Published: (2024-11-01)

Clinical Profile and Treatment Response to Conventional DMARDs in a Tertiary Care Hospital of Pakistan
by: Saira Yasmin, et al.
Published: (2024-01-01)

Impact of steroid-sparing immunosuppressive agents on tumor outcome in the context of cancer immunotherapy with highlight on melanoma: a systematic literature review and meta-analysis
by: Jennifer Strouse, et al.
Published: (2024-12-01)

Knowledge, attitude, and practice of psoriatic arthritis among patients with psoriasis
by: Aihua Mei, et al.
Published: (2024-11-01)

Psoriatic arthritis in psoriasis: optimizing the current screening system for psoriatic arthritis based on serum data from U.S. and Chinese populations
by: Zheng Lin, et al.
Published: (2024-12-01)

Psoriatic arthritis: An up to date overview
by: Simon Hackett, et al.
Published: (2020-01-01)

Comparison of active tuberculosis occurrence associated with Janus kinase inhibitors and biological DMARDs in rheumatoid arthritis
by: Jin-Won Kwon, et al.
Published: (2024-04-01)

Prevalence and association of renal disorders in Saudi adult patients with psoriasis and psoriatic arthritis: a tertiary-center retrospective cross-sectional study
by: Mishari Alrubaiaan, et al.
Published: (2025-01-01)

Guselkumab in Biologic-Naïve Patients with Active Psoriatic Arthritis in Russia: A Post Hoc Analysis of the DISCOVER-1 and -2 Randomized Clinical Trials
by: Philip Mease, et al.
Published: (2024-09-01)

“Memory and Desire”: T.S. Eliot, Reaction, Nostalgia, and Poetic Reserve in The Waste Land
by: Philippe Birgy
Published: (2019-05-01)

Correction: comparison of active tuberculosis occurrence associated with janus kinase inhibitors and biological DMARDs in rheumatoid arthritis
Published: (2024-12-01)

Managing RS3PE: Diagnostic approach, initial steroid response, and long-term management with DMARDs
by: Dasi Sharath Chandra, et al.
Published: (2024-09-01)

Combined semiquantitative nail-enthesis complex ultrasonography and capillaroscopy in psoriasis and psoriatic arthritis
by: Giacomo Cafaro, et al.
Published: (2025-01-01)

Impact of coronavirus disease 2019 on psoriatic arthritis: A multiregional observational study
by: Ranran Yao, et al.
Published: (2024-12-01)

TS SPECIMEN LIFE PREDICTION OF HIGH-STRENGTH STEEL RESISTANCE SPOT WELDS
by: ZHANG Yu, et al.
Published: (2016-01-01)

Diagnostic and prognostic values of tsRNAs in lung cancer: a meta-analysis
by: Cheng Tang, et al.
Published: (2025-01-01)

Relationships of dermatologic symptoms and quality of life in patients with psoriatic arthritis: analysis of two tofacitinib phase III studies
by: Peter C. Taylor, et al.
Published: (2022-07-01)

Apremilast generic for the treatment of active psoriatic arthritis: A single-center real-life experience from India
by: Sanjiv Amin, et al.
Published: (2020-01-01)

Secukinumab: A safe option to treat psoriasis and psoriatic arthritis in the presence of interstitial lung disease
by: Raja Natarajan
Published: (2019-01-01)

Misdiagnosis of Leprosy with Severe Reversal Reaction as Psoriatic Arthritis: A Case Report and Literature Review
by: Gunawan H, et al.
Published: (2025-01-01)